Trailing-twelve-month (TTM) revenue is $193.73 Billion with a year-over-year growth of +8.72%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $49,690,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q4 FY2025Period ended 2025-12-31 | $49,725,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $49,944,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q2 FY2026Period ended 2026-06-30 | $44,375,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $193,734,000,000 |
Current P/S: $31,660,139,550 market capitalization ÷ $193,734,000,000 TTM revenue = 0.16x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T19:59:59.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $44.38B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T19:59:59.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Commercial Segment | N/A | N/A | N/A | N/A | $33.7B | $42.0B |
| Health Care, Premium | $100.1B | $112.3B |
$193.73B
$193.73 Billion
+8.72%
vs. $178.20B a year ago (TTM)
+10.35%
5 Year compound annual growth rate
1 Year
+8.72%
3 Year
+9.41%
5 Year
+10.35%
10 Year
+20.52%
15 Year
+27.90%
20 Year
+26.45%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $194.78B | +$31.71B | +19.44% |
| 2024 | $163.07B | +$9.07B | +5.89% |
| 2023 | $154.00B | +$9.45B | +6.54% |
| 2022 | $144.55B | +$18.57B | +14.74% |
| 2021 | $125.98B | +$14.87B | +13.38% |
| 2020 |
TTM Growth
+8.72%
3-Year CAGR
+9.41%
5-Year CAGR
+10.35%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T19:59:59.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
| $135.6B |
| N/A |
| N/A |
| Medicaid Segment | N/A | N/A | N/A | N/A | $124.4B | $147.6B |
|---|
| Other Operating Segment | N/A | N/A | N/A | N/A | $4.9B | $5.1B |
|---|
| Service | $3.7B | $5.7B | $8.3B | $4.5B | N/A | N/A |
|---|
| $111.11B |
| +$36.48B |
| +48.87% |
| 2019 | $74.64B | +$14.52B | +24.16% |
| 2018 | $60.12B | +$11.73B | +24.25% |
| 2017 | $48.38B | +$7.78B | +19.15% |
| 2016 | $40.61B | +$17.85B | +78.41% |
